Azilsartan medoxomil and Novoeight recombinant
Determining the interaction of Azilsartan medoxomil and Novoeight recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: azilsartan medoxomil
Brand name: Edarbi
Synonyms: Edarbi, Azilsartan
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Azilsartan medoxomil-Novolin 70/30
- Azilsartan medoxomil-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Azilsartan medoxomil-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Azilsartan medoxomil-Novolin N
- Azilsartan medoxomil-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))
- Azilsartan medoxomil-Novolin N (Insulin NPH (Vials))
- Novoeight recombinant-Azithromycin
- Novoeight recombinant-Azithromycin (Systemic)
- Novoeight recombinant-Azithromycin 3 Day Dose Pack
- Novoeight recombinant-Azithromycin 5 Day Dose Pack
- Novoeight recombinant-Azithromycin Dihydrate
- Novoeight recombinant-Azithromycin Extended-Release Oral Suspension